Shilin District prosecutors Thursday appealed a not guilty ruling issued last month by a local court on OBI Pharma Chairman Michael Chang (張念慈), who was accused of insider trading in January 2017 under the Securities and Exchange Act.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan headline news
09/18/2025 10:21 AM - Business
Taiwan shares open higher
09/18/2025 09:24 AM - Business
Taipower activates 5 standby units to cope with low power reserve
09/17/2025 11:13 PM - Business
Taiwan Expo opens in the Philippines; US$50m in business deals expected
09/17/2025 10:58 PM - Culture
'Taiwan Travelogue' translator nominated for 2 translation awards in U.S.
09/17/2025 09:53 PM